MedPath

The Neuroprotection of Sevoflurane Preconditioning on Intracranial Aneurysm Surgery

Not Applicable
Conditions
Brain Ischemia
Interventions
Procedure: Sevo continuous inhalation
Procedure: Sev-I group
Registration Number
NCT01204268
Lead Sponsor
Xijing Hospital
Brief Summary

The current study is designed to clarify the neuroprotective effect of sevoflurane preconditioning on the patients underwent intracranial aneurysm surgery.

Detailed Description

The current study is designed to clarify the neuroprotective effect of sevoflurane preconditioning on the patients underwent intracranial aneurysm surgery. The patients with cerebral aneurysm will be recruited in current study. The sevoflurane preconditioning will be performed before the surgical procedure. The neurological injury biomarkers, such as S-100b and NSE will be detected. The neurological function and recovery will be assessed after the surgery.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Patient under intracranial aneurysm surgery.
Exclusion Criteria
  • Patients who refused to participate or who had a history of chemotherapy/convulsions two weeks prior to admission, stroke/cardiopulmonary resuscitation/head trauma three months prior to admission, Alzheimer's disease, amyotrophic lateral sclerosis, and prior melanoma were excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sevo-C groupSevo continuous inhalationPatients will receive the anesthesia with continuous inhalation of sevoflurane.
Sevo-I groupSev-I groupSevoflurane will be given before the cerebral artery clip as a preconditioning procedure for the coming ischemia-reperfusion injury.
Primary Outcome Measures
NameTimeMethod
S-100B,NSE7 days
Secondary Outcome Measures
NameTimeMethod
Karnofsky Performance Scale,NIH stroke index, MMSE6 months

Trial Locations

Locations (1)

Xijing Hospital

🇨🇳

Xi'an, Shaanxi, China

© Copyright 2025. All Rights Reserved by MedPath